vTv Therapeutics to Present Additional Clinical Data from the STEADFAST Study of Azeliragon at the Virtual Alzheimer's Association International Conference
Presenting additional data from STEADFAST study on Tuesday at 6pm est. Alzheimer's data trial update. Traders love forward looking catalysts with tight timeline
-Hugh_Henne (Not Hef)@hugh_Henne VTVT like the consolidation. Alzheimer’s is always a huge deal... Over $3 should squeeze
-Zack Morris@mrzackmorris VTVT Long on this dip and will swing overnight.